Review




Structured Review

Proteintech ift88
Ift88, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 562 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ift88/product/Proteintech
Average 96 stars, based on 562 article reviews
ift88 - by Bioz Stars, 2026-02
96/100 stars

Images



Similar Products

96
Proteintech ift88
Ift88, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ift88/product/Proteintech
Average 96 stars, based on 1 article reviews
ift88 - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier

96
Proteintech rabbit anti ift88
Rabbit Anti Ift88, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti ift88/product/Proteintech
Average 96 stars, based on 1 article reviews
rabbit anti ift88 - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier

96
Proteintech fop h00011116 m01
(A) Immunostaining for primary cilia (red, ARL13B) and nuclei (blue, DAPI) was performed in clone #70 following treatment with siRNAs targeting negative control, <t>IFT88,</t> or KIF3A. Immunofluorescence staining confirmed a marked reduction in the number of ciliated cells after IFT88 or KIF3A knockdown compared with negative control (siNC). Scale bars, 50 µm. (B) Western blots showing ARL13B, IFT88, KIF3A, and GAPDH protein levels in clone #70 after treatment with NC, IFT88, or KIF3A siRNAs. Western blot analysis also demonstrated a significant decrease in IFT88 and KIF3A protein expression by IFT88 and KIF3A knockdown, respectively, relative to siNC. (C) Schematic diagram of the experimental procedure for siRNA knockdown and subsequent EV collection. (D) Western blots of ARL13B, ALIX, and GAPDH in cell lysates and EV pellets collected from clone #70 cultures following treatment with NC, IFT88, or KIF3A siRNAs. Unexpectedly, siRNA-mediated suppression of IFT88 or KIF3A expression increased the amounts of GAPDH, ARL13B, and ALIX in EV pellets compared with siNC-treated controls.
Fop H00011116 M01, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fop h00011116 m01/product/Proteintech
Average 96 stars, based on 1 article reviews
fop h00011116 m01 - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier

96
Proteintech anti ift88
(A) Immunostaining for primary cilia (red, ARL13B) and nuclei (blue, DAPI) was performed in clone #70 following treatment with siRNAs targeting negative control, <t>IFT88,</t> or KIF3A. Immunofluorescence staining confirmed a marked reduction in the number of ciliated cells after IFT88 or KIF3A knockdown compared with negative control (siNC). Scale bars, 50 µm. (B) Western blots showing ARL13B, IFT88, KIF3A, and GAPDH protein levels in clone #70 after treatment with NC, IFT88, or KIF3A siRNAs. Western blot analysis also demonstrated a significant decrease in IFT88 and KIF3A protein expression by IFT88 and KIF3A knockdown, respectively, relative to siNC. (C) Schematic diagram of the experimental procedure for siRNA knockdown and subsequent EV collection. (D) Western blots of ARL13B, ALIX, and GAPDH in cell lysates and EV pellets collected from clone #70 cultures following treatment with NC, IFT88, or KIF3A siRNAs. Unexpectedly, siRNA-mediated suppression of IFT88 or KIF3A expression increased the amounts of GAPDH, ARL13B, and ALIX in EV pellets compared with siNC-treated controls.
Anti Ift88, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti ift88/product/Proteintech
Average 96 stars, based on 1 article reviews
anti ift88 - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier

Image Search Results


(A) Immunostaining for primary cilia (red, ARL13B) and nuclei (blue, DAPI) was performed in clone #70 following treatment with siRNAs targeting negative control, IFT88, or KIF3A. Immunofluorescence staining confirmed a marked reduction in the number of ciliated cells after IFT88 or KIF3A knockdown compared with negative control (siNC). Scale bars, 50 µm. (B) Western blots showing ARL13B, IFT88, KIF3A, and GAPDH protein levels in clone #70 after treatment with NC, IFT88, or KIF3A siRNAs. Western blot analysis also demonstrated a significant decrease in IFT88 and KIF3A protein expression by IFT88 and KIF3A knockdown, respectively, relative to siNC. (C) Schematic diagram of the experimental procedure for siRNA knockdown and subsequent EV collection. (D) Western blots of ARL13B, ALIX, and GAPDH in cell lysates and EV pellets collected from clone #70 cultures following treatment with NC, IFT88, or KIF3A siRNAs. Unexpectedly, siRNA-mediated suppression of IFT88 or KIF3A expression increased the amounts of GAPDH, ARL13B, and ALIX in EV pellets compared with siNC-treated controls.

Journal: bioRxiv

Article Title: Enhanced release of ciliary extracellular vesicles suppresses cell migration and promotes cell aggregation

doi: 10.1101/2025.11.30.691462

Figure Lengend Snippet: (A) Immunostaining for primary cilia (red, ARL13B) and nuclei (blue, DAPI) was performed in clone #70 following treatment with siRNAs targeting negative control, IFT88, or KIF3A. Immunofluorescence staining confirmed a marked reduction in the number of ciliated cells after IFT88 or KIF3A knockdown compared with negative control (siNC). Scale bars, 50 µm. (B) Western blots showing ARL13B, IFT88, KIF3A, and GAPDH protein levels in clone #70 after treatment with NC, IFT88, or KIF3A siRNAs. Western blot analysis also demonstrated a significant decrease in IFT88 and KIF3A protein expression by IFT88 and KIF3A knockdown, respectively, relative to siNC. (C) Schematic diagram of the experimental procedure for siRNA knockdown and subsequent EV collection. (D) Western blots of ARL13B, ALIX, and GAPDH in cell lysates and EV pellets collected from clone #70 cultures following treatment with NC, IFT88, or KIF3A siRNAs. Unexpectedly, siRNA-mediated suppression of IFT88 or KIF3A expression increased the amounts of GAPDH, ARL13B, and ALIX in EV pellets compared with siNC-treated controls.

Article Snippet: The following primary antibodies were used for immunofluorescence (IF) and/or western blotting (WB): ARL13B (rabbit polyclonal, 1:1,000 for IF and WB; 17711-1-AP, Proteintech), ARL13B (mouse monoclonal, 1:50 for IF; 66739-1-Ig, Proteintech), FOP (mouse monoclonal, 1:10,000 for IF; H00011116-M01, Abnova), ALIX (rabbit polyclonal, 1:1500 for WB; 12422-1-AP, Proteintech), GAPDH (mouse monoclonal, 1:3,000 for WB; MAB374, Millipore), KIF3A (rabbit polyclonal, 1:1000 for WB; 13930-1-AP, Proteintech), IFT88 (rabbit polyclonal, 1:1,500 for WB; 13967-1-AP, Proteintech).

Techniques: Immunostaining, Negative Control, Immunofluorescence, Staining, Knockdown, Western Blot, Expressing